News Medical on MSN7 小时
RUFY1-RET fusion identified as mechanism of resistance to lorlatinib in lung cancer
A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled "Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 ...
News Medical on MSN7 小时
KAIST team discovers molecular switch to reverse cancer cells
Professor Kwang-Hyun Cho's research team has recently been highlighted for their work on developing an original technology ...